West Pharmaceutical Services, Inc. (NYSE:WST), a global company involved in innovative solutions for injectable drug administration, announced on Friday that it has received approval from its board of directors for its second-quarter 2023 dividend.
The company has approved a second quarter dividend of USD0.19 per share.
The dividend will be paid to shareholders of record at 26 April 2023 on 3 May 2023.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development